123 related articles for article (PubMed ID: 18339727)
1. Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson's disease: the PD OT trial.
Clarke CE; Furmston A; Morgan E; Patel S; Sackley C; Walker M; Bryan S; Wheatley K
J Neurol Neurosurg Psychiatry; 2009 Sep; 80(9):976-8. PubMed ID: 18339727
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB).
Clarke CE; Patel S; Ives N; Rick CE; Woolley R; Wheatley K; Walker MF; Zhu S; Kandiyali R; Yao G; Sackley CM
Health Technol Assess; 2016 Aug; 20(63):1-96. PubMed ID: 27580669
[TBL] [Abstract][Full Text] [Related]
3. Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial.
Clarke CE; Patel S; Ives N; Rick CE; Dowling F; Woolley R; Wheatley K; Walker MF; Sackley CM;
JAMA Neurol; 2016 Mar; 73(3):291-9. PubMed ID: 26785394
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trial.
Sturkenboom IH; Graff MJ; Hendriks JC; Veenhuizen Y; Munneke M; Bloem BR; Nijhuis-van der Sanden MW;
Lancet Neurol; 2014 Jun; 13(6):557-66. PubMed ID: 24726066
[TBL] [Abstract][Full Text] [Related]
5. A cluster randomised controlled trial of an occupational therapy intervention for residents with stroke living in UK care homes (OTCH): study protocol.
Sackley CM; Burton CR; Herron-Marx S; Lett K; Mant J; Roalfe AK; Sharp LJ; Sheehan B; Stant KE; Walker MF; Watkins CL; Wheatley K; Williams J; Yao GL; Feltham MG;
BMC Neurol; 2012 Jul; 12():52. PubMed ID: 22776066
[TBL] [Abstract][Full Text] [Related]
6. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT.
Ashburn A; Pickering R; McIntosh E; Hulbert S; Rochester L; Roberts HC; Nieuwboer A; Kunkel D; Goodwin VA; Lamb SE; Ballinger C; Seymour KC
Health Technol Assess; 2019 Jul; 23(36):1-150. PubMed ID: 31339100
[TBL] [Abstract][Full Text] [Related]
7. Physiotherapy versus placebo or no intervention in Parkinson's disease.
Tomlinson CL; Patel S; Meek C; Clarke CE; Stowe R; Shah L; Sackley CM; Deane KH; Herd CP; Wheatley K; Ives N
Cochrane Database Syst Rev; 2012 Aug; (8):CD002817. PubMed ID: 22895932
[TBL] [Abstract][Full Text] [Related]
8. Difficulties in activities of daily living are associated with stigma in patients with Parkinson's disease who are candidates for deep brain stimulation.
da Silva AG; Leal VP; da Silva PR; Freitas FC; Linhares MN; Walz R; Malloy-Diniz LF; Diaz AP; Palha AP
Braz J Psychiatry; 2020 Apr; 42(2):190-194. PubMed ID: 31389495
[TBL] [Abstract][Full Text] [Related]
9. Vastly Different Exercise Programs Similarly Improve Parkinsonian Symptoms: A Randomized Clinical Trial.
Tollár J; Nagy F; Hortobágyi T
Gerontology; 2019; 65(2):120-127. PubMed ID: 30368495
[TBL] [Abstract][Full Text] [Related]
10. An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.
Shaw L; Bhattarai N; Cant R; Drummond A; Ford GA; Forster A; Francis R; Hills K; Howel D; Laverty AM; McKevitt C; McMeekin P; Price C; Stamp E; Stevens E; Vale L; Rodgers H
Health Technol Assess; 2020 May; 24(24):1-202. PubMed ID: 32468989
[TBL] [Abstract][Full Text] [Related]
11. Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study.
Wade DT; Gage H; Owen C; Trend P; Grossmith C; Kaye J
J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):158-62. PubMed ID: 12531939
[TBL] [Abstract][Full Text] [Related]
12. The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.
Schrag A; Selai C; Jahanshahi M; Quinn NP
J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):67-73. PubMed ID: 10864606
[TBL] [Abstract][Full Text] [Related]
13. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.
Thomas SA; Drummond AE; Lincoln NB; Palmer RL; das Nair R; Latimer NR; Hackney GL; Mandefield L; Walters SJ; Hatton RD; Cooper CL; Chater TF; England TJ; Callaghan P; Coates E; Sutherland KE; Eshtan SJ; Topcu G
Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133
[TBL] [Abstract][Full Text] [Related]
14. Physiotherapy versus placebo or no intervention in Parkinson's disease.
Tomlinson CL; Patel S; Meek C; Clarke CE; Stowe R; Shah L; Sackley CM; Deane KH; Herd CP; Wheatley K; Ives N
Cochrane Database Syst Rev; 2012 Jul; (7):CD002817. PubMed ID: 22786482
[TBL] [Abstract][Full Text] [Related]
15. Barthel Index and modified Rankin Scale: Psychometric properties during medication phases in idiopathic Parkinson disease.
Taghizadeh G; Martinez-Martin P; Meimandi M; Habibi SAH; Jamali S; Dehmiyani A; Rostami S; Mahmuodi A; Mehdizadeh M; Fereshtehnejad SM
Ann Phys Rehabil Med; 2020 Nov; 63(6):500-504. PubMed ID: 31816448
[TBL] [Abstract][Full Text] [Related]
16. Developing a multidisciplinary rehabilitation package following hip fracture and testing in a randomised feasibility study: Fracture in the Elderly Multidisciplinary Rehabilitation (FEMuR).
Williams NH; Roberts JL; Din NU; Charles JM; Totton N; Williams M; Mawdesley K; Hawkes CA; Morrison V; Lemmey A; Edwards RT; Hoare Z; Pritchard AW; Woods RT; Alexander S; Sackley C; Logan P; Wilkinson C; Rycroft-Malone J
Health Technol Assess; 2017 Aug; 21(44):1-528. PubMed ID: 28836493
[TBL] [Abstract][Full Text] [Related]
17. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of a randomized controlled trial of a telephone-delivered problem-solving-occupational therapy intervention to reduce participation restrictions in rural breast cancer survivors undergoing chemotherapy.
Hegel MT; Lyons KD; Hull JG; Kaufman P; Urquhart L; Li Z; Ahles TA
Psychooncology; 2011 Oct; 20(10):1092-101. PubMed ID: 20821373
[TBL] [Abstract][Full Text] [Related]
19. Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial.
Antonini A; Gentile G; Giglio M; Marcante A; Gage H; Touray MML; Fotiadis DI; Gatsios D; Konitsiotis S; Timotijevic L; Egan B; Hodgkins C; Biundo R; Pellicano C;
Trials; 2018 Sep; 19(1):492. PubMed ID: 30217235
[TBL] [Abstract][Full Text] [Related]
20. Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT).
van der Marck MA; Munneke M; Mulleners W; Hoogerwaard EM; Borm GF; Overeem S; Bloem BR;
Lancet Neurol; 2013 Oct; 12(10):947-56. PubMed ID: 23988337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
